In daily life, there are always many accidents that can cause skin to be scratched or bleeding. Such wounds are prone to infection if not disinfected, and may lead to tetanus. So, when is the best time to get a tetanus shot?

The commonly mentioned tetanus shot is based on passive immunity maintenance, that is, a method of protection through the injection of anti-tetanus antitoxin after exposure to possible infection. There are two commonly used preparations: 1) Tetanus Antitoxin (TAT, derived from horses). 2) Human Tetanus Immune Globulin (TIG, derived from humans). The former requires a skin test, while the latter does not. They are slightly more expensive, costing around 50-60 yuan, and are generally within the financial reach of the general public.

TAT and TIG should naturally be injected as soon as possible after injury, generally not exceeding 24 hours, but there is still value in injection even after this period (since the risk period for tetanus infection is generally about a week, but symptoms can appear as early as 24 hours after injury, hence the sooner the injection is administered after injury, the better). The maintenance period for TAT is approximately 2-3 days, and for TIG, it is about 2-3 weeks. Currently, there is no definitive conclusion in clinical medicine on this matter, but it is roughly within this range. After exceeding this period, the risk of infection increases, and re-injection is required.

When receiving active immunity maintenance through the injection of tetanus toxoid, the relative process is relatively complicated, and it is advisable to consult a medical doctor. Generally, the situation is as follows: within 3 years after the last vaccination, it is not necessary to reinject tetanus toxoid in case of injury; for those exceeding 3 years, it is recommended to reinject once. In cases of severe environmental pollution-related injuries, in addition to injecting tetanus toxoid, it may be considered to inject TAT or TIG at another location. In fact, ideally, if there is no vaccination syndrome, in the event of possible infection, in addition to receiving maintenance through the injection of TAT or TIG, if the condition permits, it should be injected with tetanus toxoid to achieve active immunity. However, in clinical medicine, this approach is only limited to individuals, hospital clinics, and other reasons, and it is still mainly guided by the simple application of TAT or TIG.